Kawasaki, Japan

Mitsuo Takahashi


Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 81(Granted Patents)


Location History:

  • Osaka, JP (1990 - 2004)
  • Yokohama, JP (2008 - 2010)
  • Kawasaki, JP (2004 - 2012)
  • Kanagawa, JP (2003 - 2018)

Company Filing History:


Years Active: 1990-2018

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Mitsuo Takahashi: Innovator in Hepatic Disease Evaluation

Introduction

Mitsuo Takahashi is a prominent inventor based in Kawasaki, Japan, known for his significant contributions to the field of hepatic disease evaluation. With a total of 12 patents to his name, he has developed innovative methods and systems that enhance the understanding and diagnosis of fatty liver-related diseases.

Latest Patents

Takahashi's latest patents include a range of advanced technologies aimed at evaluating fatty liver-related diseases. These patents encompass a method of evaluating fatty liver-related disease, a fatty liver-related disease-evaluating apparatus, and a fatty liver-related disease-evaluating program product. His method involves obtaining amino acid concentration data from blood samples and evaluating the state of fatty liver diseases such as fatty liver, NAFLD, and NASH. Additionally, he has developed a hepatic disease-evaluating apparatus that calculates an index indicating the degree of hepatic fibrosis based on amino acid concentration data.

Career Highlights

Throughout his career, Mitsuo Takahashi has worked with notable companies, including Ajinomoto Co., Ltd. and Sumitomo Electric Industries, Limited. His work has significantly impacted the medical field, particularly in the diagnosis and management of liver diseases.

Collaborations

Takahashi has collaborated with esteemed colleagues, including Munetaka Tokumasu and Hideaki Nishizawa, contributing to the advancement of research in hepatic disease evaluation.

Conclusion

Mitsuo Takahashi's innovative work in the field of hepatic disease evaluation has led to the development of crucial diagnostic methods and systems. His contributions continue to influence the medical community and improve patient outcomes in liver disease management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…